Literature DB >> 12560214

Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor.

Joost P Schanstra1, Johan Duchene, Francoise Praddaude, Patrick Bruneval, Ivan Tack, Jacques Chevalier, Jean-Pierre Girolami, Jean-Loup Bascands.   

Abstract

Bradykinin B(2) receptor knockout mice (B(2)-/-) have been useful to study the role of bradykinin under pathological conditions. With the use of these mice, it was shown that bradykinin plays an important role in angiogenesis, heart failure, salt-induced hypertension, and kidney fibrosis. Data on the role of the bradykinin B(2) receptor under physiological conditions using these mice are controversial and scarce, because these mice have no typical phenotype. For this reason, we have studied, under physiological conditions, renal hemodynamics as well as a number of morphometric glomerular parameters of B(2)-/- mice on a homogenized genetic background and on mice bred in a pathogen-free environment. Backcrossed B(2)-/- mice had normal blood pressure and normal apparent renal hemodynamics and morphology. However, reduced renal nitrite excretion and glomerular cGMP content were found, which was associated with a reduced glomerular capillary surface area. These differences had, however, no detectable effects on renal hemodynamics. These differences between B(2)-/- and wild-type mice might become important under pathological conditions as shown by a number of studies using these bradykinin B(2) receptor knockout mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560214     DOI: 10.1152/ajpheart.01150.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.

Authors:  Masao Kakoki; Kelli A Sullivan; Carey Backus; John M Hayes; Sang Su Oh; Kunjie Hua; Adil M H Gasim; Hirofumi Tomita; Ruriko Grant; Sarah B Nossov; Hyung-Suk Kim; J Charles Jennette; Eva L Feldman; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 2.  The kallikrein-kinin system and oxidative stress.

Authors:  Yukako Kayashima; Oliver Smithies; Masao Kakoki
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

3.  Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors.

Authors:  Masao Kakoki; Catherine M Kizer; Xianwen Yi; Nobuyuki Takahashi; Hyung-Suk Kim; C Robert Bagnell; Cora-Jean S Edgell; Nobuyo Maeda; J Charles Jennette; Oliver Smithies
Journal:  J Clin Invest       Date:  2006-04-06       Impact factor: 14.808

4.  The B2 receptor of bradykinin is not essential for the post-exercise increase in glucose uptake by insulin-stimulated mouse skeletal muscle.

Authors:  G G Schweitzer; C M Castorena; T Hamada; K Funai; E B Arias; G D Cartee
Journal:  Physiol Res       Date:  2011-03-14       Impact factor: 1.881

5.  High salt-induced hypertension in B2 knockout mice is corrected by the ETA antagonist, A127722.

Authors:  I Brochu; M Houde; L Desbiens; E Simard; F Gobeil; W Semaan; G Bkaily; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

6.  Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury.

Authors:  Masao Kakoki; Robert W McGarrah; Hyung-Suk Kim; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

7.  Ontogeny of bradykinin B1 receptors in the mouse kidney.

Authors:  Ozlem Pinar Bulut; Susana Dipp; Samir El-Dahr
Journal:  Pediatr Res       Date:  2009-11       Impact factor: 3.756

Review 8.  The kallikrein-kinin system in health and in diseases of the kidney.

Authors:  Masao Kakoki; Oliver Smithies
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612

Review 9.  The kallikrein-kinin system in diabetic nephropathy.

Authors:  Hirofumi Tomita; Ryan B Sanford; Oliver Smithies; Masao Kakoki
Journal:  Kidney Int       Date:  2012-02-08       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.